CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo
Diabetes · 2024
DOI: 10.2337/db23-0811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Yajuan Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Apoptosis, Carnitine O-Palmitoyltransferase, Diabetes Mellitus, Experimental, Diabetic Nephropathies. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hubei Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Defective fatty acid oxidation (FAO) has been implicated in diabetic kidney disease (DKD), yet little is known about the role of carnitine palmitoyltransferase-1A (CPT1A), a pivotal rate-limiting enzyme of FAO, in the progression of DKD. Here, we investigate whether CPT1A is a reliable therapeutic target for DKD. We first confirmed the downregulation expression of CPT1A in glomeruli from patients with diabetes. We further evaluated the function of CPT1A in diabetic models. Overexpression of CPT1A exhibited protective effects in diabetic conditions, improving albuminuria and glomerular sclerosis as well as mitigating glomerular lipid deposits and podocyte injury in streptozotocin-induced diabetic mice. Mechanistically, CPT1A not only fostered lipid consumption via fatty acid metabolism pathways, thereby reducing lipotoxicity, but also anchored Bcl2 to the mitochondrial membrane, thence preventing cytochrome C release and inhibiting the mitochondrial apoptotic process. Furthermore, a novel transcription factor of CPT1A, FOXA1, was identified. We elucidate the crucial role of CPT1A in mitigating podocyte injury and the progression of DKD, indicating that targeting CPT1A may be a promising avenue for DKD treatment. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Hua Su, Chun Zhang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Hubei Province
- National Key Research and Development Program of China
Zitieren
APA
Xie, Y., Yuan, Q., Tang, B., Xie, Y., Cao, Y., Qiu, Y., Zeng, J., Wang, Z., Su, H., & Zhang, C. (2024). CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo. Diabetes. https://doi.org/10.2337/db23-0811
Vancouver
Xie Y, Yuan Q, Tang B, Xie Y, Cao Y, Qiu Y, et al. CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo. Diabetes. 2024. doi:10.2337/db23-0811
BibTeX
@article{Xie2024,
author = {Xie, Yajuan and Yuan, Qian and Tang, Ben and Xie, Yaru and Cao, Yiling and Qiu, Yang and Zeng, Jieyu and Wang, Zhiwen and Su, Hua and Zhang, Chun},
title = {CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0811}
}
EUVIMED